Application

17834014 · SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS

Filed 2022-06-07 · Abandoned The official file ↗ · Art unit 1614 · Examiner Haejin S Park Typical · CPC A61K 38/12 · NOVARTIS AG · NOVARTIS PHARMACEUTICAL CORPORATION

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

14.6 mo

to disposition 30.9 mo

Statutes raised

103 112

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.